Literature DB >> 16373463

Complementary and alternative medicine for upper-respiratory-tract infection in children.

Roxane R Carr1, Milap C Nahata.   

Abstract

PURPOSE: Evidence on the efficacy and safety of complementary and alternative medicine (CAM) for the prevention and treatment of upper-respiratory-tract infection (URTI) in children is reviewed.
SUMMARY: A search of the literature to June 2005 identified six clinical trials examining the use of herbal medicines and nine trials of other CAM therapies. All articles were critically evaluated for adherence to standards of efficacy and safety research. Echinacea did not reduce the duration and severity of URTI. Andrographis paniculata or echinacea decreased nasal secretions (p < 0.01) but not URTI symptoms. A combination of echinacea, propolis, and ascorbic acid decreased the number of URTI episodes, the duration of symptoms, and the number of days of illness (p < 0.001). Echinacea was associated with a higher frequency of rash compared with placebo (p = 0.008). Neither ascorbic acid nor homeopathy was effective. The efficacy of zinc was not clear, and zinc may be associated with adverse effects in children. Osteopathic manipulation decreased episodes of acute otitis media (p = 0.04) and the need for tympanostomy tube insertion (p = 0.03) in children with recurrent acute otitis media. Stress-management therapy reduced the duration of URTI compared with relaxation therapy with guided imagery or standard care (p < 0.05).
CONCLUSION: Current data are generally inadequate to support CAM for the prevention or treatment of URTI in children.

Entities:  

Mesh:

Year:  2006        PMID: 16373463     DOI: 10.2146/ajhp040613

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  Management of upper respiratory tract infections in children.

Authors:  Mf Cotton; S Innes; H Jaspan; A Madide; H Rabie
Journal:  S Afr Fam Pract (2004)       Date:  2008-03

2.  Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial.

Authors:  Giuseppe Fabio Parisi; Sara Manti; Maria Papale; Alessandro Giallongo; Cristiana Indolfi; Michele Miraglia Del Giudice; Carmelo Salpietro; Amelia Licari; Gian Luigi Marseglia; Salvatore Leonardi
Journal:  Acta Biomed       Date:  2022-05-11

3.  Otitis media and spinal manipulative therapy: a literature review.

Authors:  Katherine A Pohlman; Monisa S Holton-Brown
Journal:  J Chiropr Med       Date:  2012-09

4.  Diagnostic Value of the Triple Combination of Serum Heparin-Binding Protein, Procalcitonin, and C-Reactive Protein in Children with Acute Bacterial Upper Respiratory Tract Infection.

Authors:  Xiuqin Yang; Yumei Zhang; Hai Lin; Hui Zhong; Zhihui Wu
Journal:  J Healthc Eng       Date:  2022-03-10       Impact factor: 2.682

Review 5.  Overview of Botanical Status in EU, USA, and Thailand.

Authors:  Weena Jiratchariyakul; Gail B Mahady
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

Review 6.  The consumption of propolis and royal jelly in preventing upper respiratory tract infections and as dietary supplementation in children.

Authors:  Sevda Yuksel; Sumeyya Akyol
Journal:  J Intercult Ethnopharmacol       Date:  2016-03-31

7.  Parental knowledge and practice on antibiotic use for upper respiratory tract infections in children, in Aksum town health institutions, Northern Ethiopia: a cross-sectional study.

Authors:  Teklay Zeru; Hagos Berihu; Gerezgiher Buruh; Haftom Gebrehiwot; Mebrahtom Zeru
Journal:  Pan Afr Med J       Date:  2020-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.